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Revisiting the Thrifty Gene Hypothesis via 65 Loci
Associated with Susceptibility to Type 2 Diabetes
Qasim Ayub,1,7 Loukas Moutsianas,2,7 Yuan Chen,1 Kalliope Panoutsopoulou,1 Vincenza Colonna,1,3
Luca Pagani,1 Inga Prokopenko,2 Graham R.S. Ritchie,1,4 Chris Tyler-Smith,1 Mark I. McCarthy,2,5,6
Eleftheria Zeggini,1 and Yali Xue1,*
We have investigated the evidence for positive selection in samples of African, European, and East Asian ancestry at 65 loci associated
with susceptibility to type 2 diabetes (T2D) previously identified through genome-wide association studies. Selection early in human
evolutionary history is predicted to lead to ancestral risk alleles shared between populations, whereas late selection would result in
population-specific signals at derived risk alleles. By using a wide variety of tests based on the site frequency spectrum, haplotype struc-
ture, and population differentiation, we found no global signal of enrichment for positive selection whenwe considered all T2D risk loci
collectively. However, in a locus-by-locus analysis, we found nominal evidence for positive selection at 14 of the loci. Selection favored
the protective and risk alleles in similar proportions, rather than the risk alleles specifically as predicted by the thrifty gene hypothesis,
and may not be related to influence on diabetes. Overall, we conclude that past positive selection has not been a powerful influence
driving the prevalence of T2D risk alleles.Introduction
Type 2 diabetes (T2D) was responsible for more than three
million deaths worldwide in 20041 and is projected to be
the seventh leading cause of death by 2030.2 It shows sub-
stantial familial clustering, with an estimated lifetime risk
of 38% by the age of 80 if one parent is affected and 60%
by the age of 60 if both are affected.3 T2D has therefore
been the focus of numerous medical-genetic studies,
including candidate gene and genome-wide association
studies, which have sought to identify genetic variants
that influence the risk of developing T2D. In combination,
these studies have identified at least 65 genomic regions
associated with T2D. At most of these loci, the association
signal is driven by alleles on common haplotypes, and
transethnic and fine-mapping data suggest that the causal
allele—which typically has yet to be identified unequivo-
cally—is also common.4
Because T2D decreases quality-adjusted life expectancy
by about 11 years,5 impairs sperm parameters,6 reduces
fecundability,7 and can lead to menstrual anomalies,8 the
existence of variants that have high frequency in the
population but are disadvantageous in these ways creates
an evolutionary puzzle. Why has natural selection not
eliminated them from the population? Two classes of
explanation can be considered. The risk variants might
be, from an evolutionary perspective, effectively neutral,
for example because their effects are all individually small,
or manifest only in old age. According to this model, their
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advantage, now or in the past, so that their high frequency
would be a consequence of positive selection. This second
class of explanation has been the focus of much attention
since Neel proposed that T2D was ‘‘a ‘thrifty’ genotype
rendered detrimental by ‘progress’’’;9,10 in other words,
the genetic background that leads to disadvantageous
T2D today was advantageous in past environments. We
set out to investigate the genetic support for this hypothe-
sis. In order to do so, we first need to consider in more
detail the timescale of human evolution.
The human lineage (hominins) split from that of our
closest living evolutionary relatives, chimpanzees and
bonobos, 6–7 million years ago. Studies of hominin fossils
including examination of their teeth suggest that our early
ancestors were omnivorous, incorporating substantial
amounts of animal as well as plant foods into their diet,
especially after stone tool use became common 2.6 million
years ago.11 This mixed hunter-gatherer diet was probably
universal until the beginning of the Neolithic transition
~10 thousand years ago, when domestic plants and ani-
mals began to provide alternative food sources, leading,
in developed countries, to our current westernized diet.
In contrast, coalescence times of segments of the auto-
somes are typically of the order of one million years and
seldom more than two million years.12 Consequently, var-
iants favored during hominin evolution before twomillion
years ago would mostly be fixed in the entire human pop-
ulation; only variants arising in the last ~2 million years
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In order to formulate genetic tests of the thrifty gene hy-
pothesis, it is therefore useful to distinguish between
‘‘thrifty early’’ and ‘‘thrifty late’’ versions. The thrifty early
version seems to correspond to Neel’s view, who wrote
‘‘during the first 99 per cent or more of man’s life on earth,
while he existed as a hunter and gatherer, it was often feast
or famine’’10 and later suggested that at this early stage ‘‘a
quick insulin trigger . was an asset to our tribal, hunter-
gatherer ancestors. since it should have minimized renal
loss of precious glucose. Currently, however. overalimen-
tation in the technologically advanced nations result[s]
in . diabetes mellitus.’’9 If selection acted for millions of
years, thrifty (i.e., susceptibility) alleles should be shared
by all populations; if other great ape ancestors were also
thrifty, as seems likely, these thrifty alleles would also
be ancestral, and common derived variants at these
sites would have to arise for them to be discovered by
genome-wide association studies. We consider the model
in which hominids (the clade containing humans, other
great apes, and the ancestors linking them) were all thrifty
as the simplest version of the thrifty early hypothesis and
discuss some alternative formulations of the hypothesis in
the Discussion. The alternative, thrifty late interpretation
would be that the thrifty genotype was favored only
much later in human evolution, for example when
humans were expanding into novel environments such
as out of Africa ~60 thousand years ago, into the Americas
~15 thousand years ago, or voyaging across the Pacific after
5 thousand years ago.11 In this version, thrifty (i.e., suscep-
tibility) alleles should be derived and probably specific to
individual populations or groups of populations who expe-
rienced the particular environment.
Several previous studies have sought genetic support for
the thrifty gene (implicitly the thrifty late) hypothesis.
After rs7903146 in an intron of TCF7L2 (MIM 602228)
was identified as a risk variant,13 a detailed study of this
genomic region in 2007 identified a rapid and recent
expansion of a cluster of haplotypes, designated HapA,
indicative of positive selection in East Asia (but not Africa
or Europe) around eight thousand years ago.14 HapA, how-
ever, carried the protective rather than the risk allele. A sys-
tematic survey of the 17 risk loci (including TCF7L2)
discovered by 2009 replicated the unusual population dif-
ferentiation at TCF7L2 and reported significantly extended
haplotypes at rs10923931 within NOTCH2 (MIM 600275)
(iHS value 2.249, 2.3 percentile) but found no overall
excess of positive selection signals.15 Another study of 16
loci found unusually high levels of population differentia-
tion in the 100 kb windows surrounding the index SNPs,
with HHEX (MIM 604420) in East Asian populations being
the most highly differentiated individual gene.16 A more
recent investigation in 2012, and its follow-up in 2013,
focused on the levels of population differentiation of
12–16 T2D risk alleles and reported a systematic pattern
of increasing risk allele frequency from Africa to Europe
to East Asia specific to this condition17,18 In a study
comparing ten T2D variants in a herder and farmer popu-The Americlation from Central Asia, evidence for Neolithic and post-
Neolithic positive selection was found at some loci,
including LEPR (MIM 601007), HHEX, and PON1 (MIM
168820), but selection was spread between the populations
and acting on the protective allele.19 Thus, previous work
has sought but failed to find genetic evidence for positive
selection on T2D risk alleles and has therefore not provided
genetic support for the thrifty gene hypothesis.
In the current study, we have reinvestigated this hypoth-
esis. Three developments prompted us to do this. First, far
more susceptibility alleles have now been identified, and
we were able to investigate 65 of them, a nearly 4-fold
increase over previous studies. Second, our formulation
of the thrifty early and thrifty late hypotheses permits a
more nuanced investigation of the selective regimes.
Third, additional tests for positive selection are now
possible, including ones based on multiple whole-genome
sequences.20 Despite these advantages, we find little evi-
dence to support the thrifty gene hypothesis as an overall
explanation for the high frequency of these risk alleles, but
we do find some evidence of positive selection influencing
allele frequencies at a minority of loci.Material and Methods
Curation of the T2D Index SNPs
The 65 T2D index SNPs were chosen according to the following
criteria: all SNPs that reached genome-wide significance in any
cohort and were published prior to August 2011 were included
in our analysis. For SNPs found associated with T2D in European
cohorts, all SNPs that reached genome-wide significance in the
DIAGRAMþ study21 were included. For associations published
before 2010 and subsequently replicated successfully by Voight
et al.,21 lead SNPs reported in both the original and the
DIAGRAMþ study were included, where the two differed. Further-
more, SNPs that reached genome-wide significance in studies by
Dupuis et al.22 and Qi et al.23 were also included. For SNPs associ-
ated with T2D in Asian cohorts, signals that reached genome-wide
significance in studies by Tsai et al.,24 Yamauchi et al.,25 Shu
et al.,26 Unoki et al.,27 and Yasuda et al.28 were included in our
analysis. The majority of the SNPs were discovered in European
populations and only 13 were discovered in Asian populations.
No signals were discovered in other populations prior to August
2011.
Most of our analyses are based on the 64 SNPs that lie on auto-
somes, excluding the SNP (rs5945326) near DUSP9 (MIM 300134)
on the X chromosome. We stratified the index SNPs by allelic sta-
tus of the risk allele (ancestral or derived), effect size (large, where
the association was identified between 2006 and 2009, or small,
where that association was identified after 2009, often by meta-
analysis), and biological function (insulin resistance, reduced
beta cell function, or unclassified), based on the function of the
nearest gene. All the tests below were carried out on the complete
set of 64 as well as the stratified subgroups.
Comparison with Archaic Humans
The allelic status of each of the 65 T2D index SNPs was determined
from the EPO alignment.29 The proportion of risk alleles that
correspond to the ancestral allele was determined by directan Journal of Human Genetics 94, 176–185, February 6, 2014 177
counting. Archaic human data for the allele at each T2D index SNP
in theNeandertal30 andDenisovan31 genomeswere obtained from
the Ensembl and the high-coverage Denisovan genome,32 respec-
tively. We used Fisher’s exact test to examine the enrichment of
ancestral risk alleles in bothmodern humans and archaic genomes
compared with matched controls.Site Frequency Spectrum-Based Analyses
A custom pipeline has been established to investigate whether
or not there is enrichment for positive selection signals based
on site frequency spectrum statistics (Tajima’s D,33 Fay and
Wu’s H,34 and Nielsen et al.’s CLR value35) by using the 1000
Genomes Project Phase 1 data in a chosen set of regions or genes,
in comparison to a randomly selected list of control regions or
genes matched for length, GC content, and average recombina-
tion rate, as described previously.36 Populations were grouped
into AFR (YRI þ LWK þ ASW), ASN (CHB þ CHS þ JPT), and
EUR (CEU þ TSI þ GBR þ FIN) continental regions as the 1000
Genomes Project suggests. The pipeline has been shown to detect
selection in lists containingR10% positively selected genes.
We compared the distribution of the statistics in nonoverlap-
ping 10 kb windows in the regions 25 or 50 kb upstream and
downstream of each index SNP with the matched controls. We
divided the whole genome into similar 50 or 100 kb regions
and, after excluding the index SNP regions, generated 1,000 con-
trol regions for each index SNP that were matched for GC content
and recombination rate. A permutation test was used to assess
whether or not the distributions of the test statistics were signifi-
cantly different between the index SNP and control regions.
The nearest genes to the index SNPs were considered as candi-
date genes and a matched list of control genes was generated
from the Ensembl Archives database (Ensembl 54: NCBI Build
36). Fifty-five genes were tagged by the 65 index SNPs, but four
genes were excluded from subsequent analyses. These were
DUSP9 on the X chromosome, KLF14 (MIM 609393) for which
there were no recombination data, and C2CD4A (MIM 610343)
and C2CD4B (MIM 610344) that were not listed in NCBI36.
The 1,000 matched control sets of genes were generated and
the enrichment of positive selections signals were analyzed as
described previously.36CMS Analysis
To further interrogate the T2D-associated regions for evidence of
positive selection, we used amodification of the composite of mul-
tiple signals (CMS) score.37 The CMS provides an approximate
posterior probability that a variant is under selection based on
five tests: three measures of haplotype length (iHS, XP-EHH,
DiHH), one of population differentiation (FST), and one of the fre-
quency difference of the derived allele (DDAF). For our analysis, a
missing value for any of the five scores was replaced by the mean
value for that test across all sites. This was done so as to be able to
include this site in the analysis, because otherwise its CMS value
would have been zero. The statistic employed for all analyses pre-
sented here is the rank of each variant based on its CMS value.
We calculated the CMS value for all 3,021,594 autosomal SNPs
included in the third phase of the HapMap project across the
European (CEU), African (YRI), Chinese (CHB), and Japanese
(JPT) populations.38 For the latter, the data were pooled
(CHBþJPT). For each of the index T2D SNPs, we defined a 25 or
50 kb region on either side as a ‘‘T2D index region’’ and compared
the highest CMS value of that region to 2,000 randomly picked re-178 The American Journal of Human Genetics 94, 176–185, Februarygions of the same length across the genome. The latter were
matched for GC content (GC% of the random regions was
98.75%–101.25% of the GC% of the T2D regions) and average
recombination rate. A Mann-Whitney U test was used to compare
the difference in CMS ranks between T2D regions and matched
control regions, and the final p values were obtained after aver-
aging over 10,000 iterations.
Haplotype Diversity
Nei’s haplotype diversity was calculated for regions of 10 kb
surrounding the 64 autosomal index SNPs by using the 1000
Genomes Phase 1 sequencing data, grouping the populations in
the same way as for the site frequency spectrum tests.39 We
randomly generated 1,000 control sets for each of the 64 SNPs
drawn from a subset of the 1000 Genomes Phase I data that con-
tained only markers found in the commonly used genotyping
platforms (n ¼ 2,010,212 markers), matched by derived allele fre-
quency (50.001) in the population that the association was
discovered in. The p value was obtained by comparing with
60,760 random genome frequency-matched control regions by a
one-sided Kolmogorov-Smirnov Test.
Pairwise FST
The T2D index SNP and matched control SNP frequencies in 849
samples belonging to the AFR, ASN, and EUR continental groups
were extracted from Phase 1 of the 1000 Genomes Project.39 Pair-
wise FST between the three groups was calculated for each of the 64
index SNPs as well as for the other biallelic autosomal SNPs avail-
able for those populations. 1,000matched control SNPs for each of
the index SNPs were chosen by matching the global derived allele
frequency to 50.001. The distribution of the 64 index SNPs as a
whole or stratified by subgroup as described above was compared
to its matched controls by a Mann-Whitney U test.
Identification and Analysis of Individual Genes
Showing Evidence of Positive Selection
We assigned an empirical p value to each of the 64 autosomal T2D
SNPs by using the most significant p value within the surrounding
100 kb region from the site frequency spectrum-based tests in the
YRI, CEU, and CHB populations and the empirical p values (rank
p values) obtained from its 1,000 matched controls for the pair-
wise FST and haplotype diversity tests. (We did not use the CMS
value because this also includes haplotype-based and pairwise
FST tests, and also because our CMS values are based on genotype
data with complex ascertainment.) Then we calculated a com-
bined p value by Fisher’s method,40 which is 2Pln P (here:
2 3 (ln PSFS þ ln Phaplotype diversity þ ln PFST1 þ ln PFST2), where
FST1 and FST2 are the two FST values possible for each continental
comparison); it has a c2 distribution with degrees of freedom
equal to two times the number of the tests (here, eight). We
used this combined p value to rank the individual genes. We set
the p value cut off based on a Bonferroni correction (46 tests,
3 populations, 0.05/(46*3) ¼ 3.6 3 104); 18 out of the 64 SNPs
are in high LD with another SNP and were not considered as an
independent test.
We constructed median-joining networks41 of the inferred hap-
lotypes in high LD (r2R 0.95) with the index SNP for interesting
regions. Networks were based on phased haplotypes generated
from the 1000 Genomes Phase 1 low coverage resequencing data
for 88 YRI, 85 CEU, and 86 CHB samples. Times to the most recent
common ancestor of candidate selected haplotype clusters, and6, 2014
their standard deviations, were estimated by the rho statistic
implemented in the network program.41
Prediction of Functional Impact of SNPs
We identified all SNPs in linkage disequilibrium with the auto-
somal index SNPs at r2 cutoffs of 0.4 and 0.95 in the European
sample from the 1000 Genomes Project Phase 1 data.39 We anno-
tated these variants by using custom software that identified any
overlapping genes and regulatory annotations. Gene annotations
were taken from GENCODE release 1542 and regulatory annota-
tions from the ENCODE project.43 All variants were assigned
a functional annotation (stop_gained, frameshift, splice_site,
stop_lost, missense, UTR, ncRNA; bound_TF_motif, TFBS, DNase_
footprint, DNase_peak, synonymous, intronic, or intergenic) and
given a rank from 1 to 14 in this order.
For each index SNP, we used these ranks to select the highest
ranked candidate functional variant from the set of linked vari-
ants. Where there were multiple candidate SNPs with the same
rank, one was selected arbitrarily. We used the same software to
annotate the index SNP, and we report this annotation and its
associated rank in Table S1 (available online) along with the candi-
date functional variant.Results
We compiled a list of 65 index SNPs that influence suscep-
tibility to T2D: the majority of these SNPs were annotated
as intronic (39) or intergenic (15), five were nonsynony-
mous, three lay in a 30 UTR, and three were within 5 kb
of a transcript start site (Table S1).
No Evidence to Support the Thrifty Early Hypothesis
If the thrifty early hypothesis as described above is right,
we expect causative T2D risk alleles to correspond to the
ancestral states and the index SNP risk alleles to be
enriched for ancestral states. However, we found that
only about half of the risk alleles were ancestral (36/65,
55%), not significantly different from the matched con-
trols genome-wide. Our analysis has power to detect an
enrichment of 72% ancestral states (47/65). Similarly,
only 45% (28/62) of the SNPs with the highest functional
ranking (see Material and Methods) in high LD with the
index SNPs, i.e., possible causal alleles, were ancestral.
This is not significantly different from the index SNP pro-
portion (Fisher’s exact test p¼ 0.285). Therefore, the index
SNPs and the candidate functional SNPs showed the same
lack of enrichment for the ancestral state.
We also expect to see enrichment of ancestral status for
the risk alleles in archaic humans (Neandertals and Deniso-
vans): if thrifty variants have been selected for millions of
years and become fixed, the allele carried by these homi-
nins would be ancestral for humans. In Neandertals,30
44/65 index SNP positions were called, of which 38 were
ancestral and 53% (20/38) of these were risk alleles. In
Denisova,31,32 all index SNPs were called, of which 56
were ancestral and 57% (32/56) of these were risk alleles.
These are again similar to controls. One SNP was derived
in Denisova but ancestral in Neandertals (Table S1). AThe Americsimilar proportion of the Neandertal (3/6) and Denisova
(4/9) genotypes were homozygous for the derived risk
allele (Table S2).
No Support for the Thrifty Late Hypothesis
If the thrifty late hypothesis is true, we should be able to
detect an enrichment of positive selection signals around
the index SNPs, acting on the risk allele. We have applied
three classes of test, based on (1) site frequency spectrum
(Tajima’s D,33 Fay and Wu’s H,34 and Nielsen et al.’s
CLR35); (2) haplotype characteristics (the composite of
multiple signals [CMS]37 and haplotype diversity); and
(3) population differentiation (pairwise FST).
44 Although
not entirely independent, and, strictly, detecting depar-
tures from neutrality that may or may not be best
explained by positive selection, these tests should in com-
bination capture signals of positive selection that has acted
after ~60,000 years ago when modern humans expanded
out of Africa and up until the last few thousand years. Tests
(1) and (2) are sensitive mainly to ‘‘classic’’ sweeps where
selection acts on a new variant, whereas test (3) is in addi-
tion sensitive to selection on standing variation.
Site Frequency Spectrum-Based Analyses
We compared combined p values of the three site fre-
quency spectrum-based statistics in populations of African
(AFR: YRI þ LWK þ ASW), European (EUR: CEU þ TSI þ
GBR þ FIN), or East Asian (ASN: CHB þ CHS þ JPT)
ancestry between the set of 64 autosomal index SNPs
(windows of 50 or 100 kb centered on each SNP) and
matched control regions. The distributions of the statistics
for the index SNPs were not different from the matched
controls (Figure 1A, Table S3). Therefore, we conclude
that there is no overall enrichment of signals of positive
selection detectable by these tests around the T2D index
SNPs. Because strong LD in the human genome seldom
extends farther than 100 kb, these tests should also detect
selection on the causative variant.
We also found no enrichment of positive selection sig-
nals after stratification of these SNPs by allelic status of
the risk allele, effect size, and biological function, except
for beta-cell function in Africa, which just exceeded the
significance threshold (p ¼ 0.0002). More detailed exami-
nation showed that this was due to the signal in Tajima’s
D, and not the other two tests, which is better explained
by negative selection or population substructure than pos-
itive selection (Figure 1A, Table S3). In addition, we further
compared statistics for the nearest gene to each index SNP
with matched control genes and observed no significant
difference either (data not shown).
Haplotype-Based Analyses
We examined CMS values for the 64 autosomal index SNPs
in three populations (YRI, CEU, and CHB þ JPT) by using
data from the third phase of the HapMap project.38 To
allow for the possibility that the index SNP may not be
the causal SNP, in conjunction with the suggested ability
of the CMS test to pinpoint the causal SNP,37 we expanded
the analysis to include the SNP with the highest CMS valuean Journal of Human Genetics 94, 176–185, February 6, 2014 179
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Figure 1. Tests for Positive Selection in
the Group of 64 Autosomal T2D Suscepti-
bility Loci
Tests were based on (A) the site frequency
spectrum (Tajima’s D, Fay and Wu’s H,
and Nielsen et al.’s CLR), (B) the composite
of multiple signals (CMS), (C) haplotype
diversity, or (D) population differentiation
(pairwise FST) in a window of 25 kb on
either side of the index SNP, except haplo-
type diversity, which used a window of
5 kb on each side. In each test, we exam-
ined either the combined set of loci (All)
or subsets based on biological function
(BF), the ancestral/derived status of the
risk allele (RAS), or the effect size (ES), in
each population or population pair. The
results are summarized as the combined
–log10 of the p value; the threshold for
significance after Bonferroni correction is
shown by the dotted line.in a window of 50 or 100 kb centered on each index SNP.
We found no significant difference in the values compared
with matched control SNPs, either overall or in the
different stratification groups (Figure 1B, Table S3).
In an alternative haplotype-based approach, we exam-
ined haplotype diversity in 10 kb windows around the
index SNPs compared with matched controls in popula-
tions of similar continental origin (AFR, EUR, and ASN),
using the 1000 Genomes Phase 1 data set.39 We did not
see overrepresentation of reduced haplotype diversity
in any continental group compared with genome-wide
matched controls, either overall or after stratification
(Figure 1C, Table S3).
Population Differentiation-Based Analyses
Pairwise FST values
44 between the three continental groups
AFR, EUR, and ASN based on the 1000 Genomes Project
Phase 1 data set39 were calculated. The distributions of
the pairwise FST values between the three continental
groups for the 64 autosomal index SNPs are not signifi-
cantly different from the matched controls as a whole,
nor in the stratification groups (Figure 1D, Table S3). There-
fore, there is no evidence for enrichment of positive selec-
tion of the T2D SNPs based on unusual levels of population
differentiation.
Overall, we did not find any enrichment for positive
selection acting on the 64 T2D SNPs based on these
different tests. Thus, we conclude that there is no evidence
to support the thrifty late hypothesis either.
Individual Genes Showing Nominal Evidence of
Positive Selection
The analyses above test whether, as a group, there was a
consistent signal of selection. However, failure to detect
signal across all 64 loci does not necessarily preclude sig-
nals at some of the loci when tested individually. We
now discuss these individual loci.180 The American Journal of Human Genetics 94, 176–185, FebruaryTo identify outliers in an objective way, we combined (1)
the smallest p value from the site frequency spectrum-
based tests in the 100 kb window surrounding each index
SNP, and the empirical p values from (2) the diversity test
and (3) the pairwise FST test as a single combined p value,
because these p values are independent.40 Then we applied
a significance cut-off of 3.6 3 104 to correct for multiple
tests as described in the Material and Methods. We found
that five index SNPs (rs340874, rs3923113, rs6780569,
rs1470579, and rs1552224) at five GWAS loci (near
PROX1 [MIM 601546], GRB14 [MIM 601524], UEB2E2
[MIM 602163], IGF2BP2 [MIM 608289], and ARAP1
[MIM 606646]) in African populations, three index SNPs
(rs340874, rs1531343, and rs8042680) at three GWAS
loci (those near PROX1, HMGA2 [MIM 600698], and
PRC1 [MIM 603484]) in European populations, and
nine index SNPs (rs10923931, rs11899863, rs7578597,
rs3923113, rs10010131, rs1801214, rs896854, rs7903146,
and rs8042680) at seven GWAS loci (NOTCH2, THADA
[MIM 611800], GRB14, WFS1 [MIM 606201], TP53INP1
[MIM 606185], TCF7L2, and PRC1) in East Asian popula-
tions showed significant signals (Figure 2). Three genes
showed selection signals in two populations: PROX1 in
Africans and Europeans, GRB14 in Africans and Asians,
and PRC1 in Europeans and Asians. Among all the selected
regions, TCF7L2, NOTCH2, and THADA have been
identified as showing signals of selection by previous
studies.14–16,19 The other nine regions are newly identified
in this study. We failed to pick up the previously reported
highly differentiated signals near CDKAL1 (MIM 611259)
and HHEX/IDE (MIM 146680), although these were close
to the significance threshold (Figure 2).
We constructed median-joining networks to visualize
the haplotype relationships of the genomic regions in
high LD (r2R 0.95) with these index SNPs and to illustrate
the networks for two of these regions, those near NOTCH26, 2014
Figure 2. Tests for Positive Selection in the 64 Individual Autosomal T2D Susceptibility Loci
Tests were based on the site frequency spectrum (Tajima’sD, Fay andWu’sH, and Nielsen et al.’s CLR), haplotype diversity, or population
differentiation (pairwise FST), and each region or each index SNP was examined separately in each population. The results are summa-
rized as the combined –log10 of the p value; the threshold for significance after Bonferroni correction is shown by the dotted line.and HMGA2 (Figures 3 and 4). In the NOTCH2 network,
selected in East Asians, the YRI haplotypes are diverse
and scattered, whereas CHB showed massive expansion
of the same haplotype, with multiple independent one-
and two-step derivatives of this central haplotype also pre-
sent (Figure 3), as also in CEU where the combined p value
was just below the threshold value. Together, the central
haplotype and its derivatives account for 95% of CHB
haplotypes and 87% of CEU haplotypes. This pattern sup-
ports the hypothesis of positive selection on the central
haplotype in the CHB and possibly CEU, but not the
YRI, beginning sufficiently long ago for variants of the
haplotype to accumulate, approximately 185 5 thousand
years ago.41 In the HMGA2 network, there are moderately
common haplotypes in all three populations, but the
haplotype with the highest population frequency occurs
in the CEU (64%, compared with maximum frequencies
of 43% in the CHB and 30% in the YRI), along with one-
and two-step derivatives (Figure 4). This pattern similarly
suggests positive selection, specific to the CEU and begin-
ning about 30 5 19 thousand years ago. In both cases,
the likely selected haplotype carries the protective allele
at the index SNP.
All of the 14 SNPs that showed signatures of positive
selection in the combined tests lay on a common haplo-
type in the selected population but not in other popula-
tions; this finding is expected because the tests are powered
only to detect selection of a common allele, but provides
some additional support for selection. In 8/14, selection
was detected on the protective allele in at least one of the
populations, or 8/12 if we treat the index SNPs within
high LD (r2 > 0.95) as a single event (Table S1). In con-
clusion, these analyses confirm that there are good
candidates for positive selection at a small subset of the
T2D-associated loci, although even in this subset, selection
is divided between the risk and protective alleles whereas itThe Americis predicted to be for the risk allele by the thrifty gene
hypothesis.Discussion
The medical impact of T2D, already a leading cause of
death,2 with more than 80% of the mortality occurring
in low- and middle-income countries,45 has raised interest
in understanding its evolutionary-genetic basis, as well as
discovering underlying pathways that may have more
immediate medical relevance. Several previous studies
based on small numbers of loci have unsuccessfully sought
evidence of positive selection on risk alleles14–17,19 as pre-
dicted by the thrifty late interpretation of Neel’s hypothe-
sis,9,10 instead finding that a small subset of protective
alleles may have been positively selected.
Now, a greatly increased number of index SNPs, and
additional resources for detecting positive selection, are
available. We have therefore been able to carry out a com-
prehensive reinvestigation of this question. The outcome
was consistent with many of the previous studies: no sig-
nificant overall enrichment for positive selection on the
loci as a group, but evidence for positive selection at a small
number of individual loci. This proportion was similar to
the level of positive selection found within a set of
randomly chosen matched loci (which were chosen blind
to evidence for positive selection) and therefore did not
provide a signal in the group test. Selection acted on
both the risk and protective alleles. We did not, however,
find support for unusual levels of population differentia-
tion at T2D index SNPs, reported previously,17,18 despite
examining far more SNPs (64 versus 12–16). Of the ten
SNPs analyzed in detail by Chen et al.,17 seven were
included in our set and two others were in high LD with
two of ours. These nine SNPs did show higher FST valuesan Journal of Human Genetics 94, 176–185, February 6, 2014 181
Figure 3. Positive Selection at the NOTCH2 Locus
(A) Region on chromosome 1 that spans NOTCH2 showing
GENCODE (v. 14) transcript annotation (blue, protein coding
transcripts; green, non-protein coding transcripts) and variant
(dbSNP 137, NHLBI Exome SNPs and Indels) tracks (red, nonsy-
nonymous and essential splice site variants; green, synonymous;
black, splice site). The NHGRI GWAS Catalog track displays the
position of the index SNP (rs10923931) and a highly differentiated
variant (rs835574) observed between the AFR and EUR popula-
tions in the 1000 Genomes Project. The –log10p of the combined
p value (boxed area) were generated from the separate probabilities
of Tajima’s D, Fay and Wu’s H, and Nielsen et al.’s CLR. The
threshold, represented by the dashed line, incorporates the 5%
FDR for each population. Peaks above the cut-off represent regions
enriched for positive selection in the CEU and CHBþJPT.
(B) A closer look at the haplotype networks in a region that is in
high LD (r2 R 0.95) in CEU (gray area in A). Phased haplotypes
were used to make the median joining networks. ENCODE anno-
tation shows regions of open chromatin (Digital DNase I Hyper-
sensitivity Clusters) and chromatin state segmentation in four
cell lines (lymphoblastoid [GM12878], human umbilical vein
endothelial [HUVEC], liver [HepG2], and human skeletal muscle
182 The American Journal of Human Genetics 94, 176–185, Februarythan the remaining SNPs in our analyses (p ¼ 0.046,
Mann-Whitney U test), confirming that high population
differentiation is a feature of these variants, but not of
T2D-associated variants in general and perhaps a conse-
quence of the particular ascertainment scheme used in
these studies, which enriched for genes with large effect
(p ¼ 0.002, Fisher exact test). Although the number of
T2D-associated loci is likely to increase in the future, we
have examined a sufficiently large sample that the lack of
support for the thrifty gene hypothesis seems unlikely to
change. We therefore need to consider its implications.
Most of the analyses have been performed in the index
SNP, which will usually not be the causative SNP. Would
the results be very different if we were able to test the set
of causative SNPs directly? This seems unlikely. The index
SNP is expected to be in strong LD with the causative allele
and to share properties such as location in the genome and
frequency. When we attempted to increase the number of
potentially causative SNPs in the set by identifying the SNP
with the highest functional ranking in each window (Table
S1), similar results were obtained.We have presentedmany
of our analyses in terms of the gene nearest to the index
SNP, because these names are more memorable than the
SNP rs numbers. Most of the index SNPs, and probably
most of the causal SNPs, will be regulatory, and thus poten-
tially may act on a distal gene instead of the nearest one.
Our analyses are based on the numbers, locations, and
properties of the selection signals, except for the stratifica-
tion of signals according to biological function, and so
misidentification of the affected gene would have little
effect on our conclusions.
The thrifty gene hypothesis can be interpreted in thrifty
early and thrifty late forms, the former corresponding
better to Neel’s view, but the latter being the more com-
mon interpretation by geneticists. We have suggested
that according to the thrifty early hypothesis, risk variants
would have been selected for during most of human
evolutionary history and thus would be ancestral alleles
shared by prehominins and most present-day popula-
tions. If the human-chimpanzee ancestor had not been
thrifty, but early hominins had been, thrifty alleles
would be human specific and appear as fixed human-
chimpanzee differences. In order for such differences to
be detected in association studies, common variation
would need to have arisen subsequently. In this case,
thrifty alleles would generally be derived with respect to
other great apes, and our results also exclude this scenario.
Neither the current nor previous studies have found
genetic support for the thrifty late hypothesis, although
further studies in populations with histories of extreme
famine-abundance cycles within the last few thousand
years would still be of interest.myoblast [HSMM]). The region is associated with transcription
and candidate enhancer regions are observed in HSMM. This is
also supported by presence of binding sites for transcription fac-
tors (including IRF7) in its vicinity.
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Figure 4. Positive Selection near HMGA2
(A) Region on chromosome 12 upstream of HMGA2 showing
GENCODE (v. 14) transcript annotation (blue, protein coding
transcripts; green, non-protein coding transcripts) variant (dbSNP
137) and NHGRI GWAS Catalog tracks with the index SNP
(rs1531343) highlighted. ENCODE annotation shows regions of
open chromatin (Digital DNase I Hypersensitivity Clusters), CpG
islands, and chromatin state segmentation in four cell lines
(GM12878, HUVEC, HepG2, and HSMM). The region is associated
with transcription and candidate enhancer and promoter
regions are observed in three cell lines. deCode Recombination
Maps tracks show a male specific recombination region (blue).
The –log10p of the combined p value (boxed area) show peaks
above the cut-off that represent regions enriched for positive selec-
tion in the CEU.
(B) A closer look at the haplotype networks in a region that is in
high LD (r2R 0.95) in CEU (gray area in A). Candidate enhancer
regions are observed in HUVEC and HSMM cell lines. There is a
binding site for the transcription factor IRF7 in their vicinity.A finding common to several studies has been the evi-
dence for positive selection on a proportion of protective
alleles. It has been suggested that the relatively low fre-
quency of T2D in populations of European ancestry,The Americcompared to non-Europeans with similar lifestyles, might
reflect selection for diabetes resistance in Europeans.46
Indeed, all three index SNPs showing positive selection
in Europeans show selection on the protective allele (Table
S1). Nevertheless, similar selection is seen at three of seven
independent index SNPs in East Asians and two out of
five in Africans. Overall, it is far from clear that these vari-
ants have been selected because of their small influence on
T2D risk; selection may well have acted on other aspects of
their biology.
In conclusion, we have performed the largest investiga-
tion of the genetic basis of the thrifty gene hypothesis
thus far and find that it is not supported. It therefore seems
that selection for thrifty alleles earlier in human history,
together with a change in lifestyle, do not account for
the levels of T2D susceptibility in current populations. It
is more likely that T2D risk variants have been, for most
of human evolutionary history, effectively neutral.Supplemental Data
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